The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - MSD Oncology; Roche
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Safety and efficacy of YBL-006, an anti-PD-1 monoclonal antibody in advanced solid tumors: A phase I study.
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; Merck Serono; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER
 
John J. Park
No Relationships to Disclose
 
Keun Wook Lee
Honoraria - Boryung; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Daiichi Sankyo; ISU ABXIS; MSD; Vifor Pharma
Research Funding - ABL Bio (Inst); ALX Oncology (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); GC Pharma (Inst); InventisBio (Inst); Leap Therapeutics (Inst); LSK BioPharma (Inst); Macrogenics (Inst); MedPacto (Inst); Merck KGaA (Inst); MSD (Inst); Oncologie (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Trishula Therapeutics (Inst); Y-BIOLOGICS (Inst); Zymeworks (Inst)
 
Seung Tae Kim
No Relationships to Disclose
 
Virote Sriuranpong
Honoraria - Amgen; AstraZeneca; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; Roche
Research Funding - AstraZeneca; MSD Oncology; Novartis; Pfizer; Roche
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Eisai; Indivumed; LG Chem; MSD Oncology
Speakers' Bureau - BMS/Ono; Eisai; Lilly; MSD Oncology
Research Funding - ASLAN Pharmaceuticals; Bayer; Bristol-Myers Squibb; Eisai; Immunomet; medpacto; MSD Oncology; Roche/Genentech; Sillajen
 
Changhoon Yoo
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD Oncology; SERVIER
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER
 
Bhumsuk Keam
Honoraria - AstraZeneca; Merck; MSD Oncology
Consulting or Advisory Role - ABL Bio; CBS Bioscience; Cellid; Handok; NeoImmuneTech; Trial Informatics
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Dhanusha Sabanathan
No Relationships to Disclose
 
Se Hyun Kim
Consulting or Advisory Role - Ono Pharmaceutical
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; Celgene; MediRama; Merck Serono; SERVIER
Research Funding - Celgene; medpacto; SERVIER
 
Napa Parinyanitikul
No Relationships to Disclose
 
Min Hwan Kim
Research Funding - AstraZeneca; Daewoong Pharmaceutical
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Myungsuk Kim
Employment - Y-Biologics
 
Jaebong Yoon
Employment - Y-Biologics
Stock and Other Ownership Interests - Y-Biologics (Inst)
 
Han Seung Lee
Employment - LG Chem; Y-Biologics
Leadership - LG Chem; Y-Biologics
Stock and Other Ownership Interests - LG Chem; Y-Biologics
Patents, Royalties, Other Intellectual Property - LG Chem
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Medpacto; Y-Biologics
Consulting or Advisory Role - Idience; Medpacto; Y-Biologics